Global Gastrointestinal Drugs Market Trends And Strategies Of Major Players In The Gastrointestinal Drugs Market 2021-2030
10 Mar, 2021
The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.
Global Gastrointestinal Drugs Market Size And Drivers:
The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The market is expected to reach $62.19 billion in 2025 at a CAGR of 6%.
The aging population profile of most countries contributed to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally contributed significantly to the growth of the market during the historic period.
Request For A Sample For The Global Gastrointestinal Drugs Market Report:
Trends In The Global Gastrointestinal Drugs Market
Major companies in the gastrointestinal drug industry are investing in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs which can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are usually injected and only a fraction of the administered dose reaches the disease sites in the gastrointestinal tract.
Global Gastrointestinal Drugs Market Segments:
The global gastrointestinal drugs market is further segmented based on type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrheals.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration: Oral, Parenteral, Others.
By Drug Classification: Branded Drugs, Generic Drugs.
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
By Geography: The global gastrointestinal drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Among these regions, North America is the largest region in the global gastrointestinal drugs market, accounting for 48% of the total market.
Read More On The Report For The Global Gastrointestinal Drugs Market At:https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2020-30-covid-19-implications-and-growth
Gastrointestinal Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides gastrointestinal drugs market overviews, analyzes and forecasts market size and growth for the global gastrointestinal drugs market, gastrointestinal drugs market share, gastrointestinal drugs market players, gastrointestinal drugs market segments and geographies, gastrointestinal drugs market’s leading competitors’ revenues, profiles and market shares. The gastrointestinal drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.